rs679620

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -16 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_StrongBP6_Strong

The NM_002422.5(MMP3):c.133A>G (p.Lys45Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.526 (AC=846,122) in the gnomAD database across 1,608,044 control chromosomes, including 227,326 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.688. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.58 ( 25701 hom., cov: 31)
Exomes 𝑓: 0.52 ( 201625 hom. )

Consequence

MMP3
NM_002422.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.176

Publications

196 publications found
Variant links:
Genes affected
MMP3 (HGNC:7173): (matrix metallopeptidase 3) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. This gene encodes an enzyme which degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The enzyme is thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002422.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -16 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6
ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6884 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002422.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP3
NM_002422.5
MANE Select
c.133A>Gp.Lys45Glu
missense
Exon 2 of 10NP_002413.1P08254

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP3
ENST00000299855.10
TSL:1 MANE Select
c.133A>Gp.Lys45Glu
missense
Exon 2 of 10ENSP00000299855.5P08254
MMP3
ENST00000524478.1
TSL:4
n.104A>G
non_coding_transcript_exon
Exon 2 of 4ENSP00000435255.1E9PKX2

Frequencies

GnomAD3 genomes
AF:
0.575
AC:
87307
AN:
151766
Hom.:
25663
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.653
Gnomad AMI
AF:
0.582
Gnomad AMR
AF:
0.638
Gnomad ASJ
AF:
0.614
Gnomad EAS
AF:
0.673
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.605
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.491
Gnomad OTH
AF:
0.559
GnomAD2 exomes
AF:
0.580
AC:
142818
AN:
246160
AF XY:
0.576
show subpopulations
Gnomad AFR exome
AF:
0.653
Gnomad AMR exome
AF:
0.703
Gnomad ASJ exome
AF:
0.606
Gnomad EAS exome
AF:
0.666
Gnomad FIN exome
AF:
0.589
Gnomad NFE exome
AF:
0.490
Gnomad OTH exome
AF:
0.551
GnomAD4 exome
AF:
0.521
AC:
758719
AN:
1456160
Hom.:
201625
Cov.:
37
AF XY:
0.526
AC XY:
380836
AN XY:
724274
show subpopulations
African (AFR)
AF:
0.659
AC:
21951
AN:
33328
American (AMR)
AF:
0.695
AC:
30762
AN:
44270
Ashkenazi Jewish (ASJ)
AF:
0.609
AC:
15862
AN:
26038
East Asian (EAS)
AF:
0.679
AC:
26897
AN:
39620
South Asian (SAS)
AF:
0.674
AC:
57923
AN:
85936
European-Finnish (FIN)
AF:
0.584
AC:
31084
AN:
53198
Middle Eastern (MID)
AF:
0.615
AC:
3534
AN:
5750
European-Non Finnish (NFE)
AF:
0.486
AC:
537959
AN:
1107874
Other (OTH)
AF:
0.544
AC:
32747
AN:
60146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
16292
32584
48877
65169
81461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16076
32152
48228
64304
80380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.575
AC:
87403
AN:
151884
Hom.:
25701
Cov.:
31
AF XY:
0.584
AC XY:
43358
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.654
AC:
27068
AN:
41408
American (AMR)
AF:
0.639
AC:
9736
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.614
AC:
2131
AN:
3468
East Asian (EAS)
AF:
0.673
AC:
3471
AN:
5158
South Asian (SAS)
AF:
0.697
AC:
3353
AN:
4810
European-Finnish (FIN)
AF:
0.605
AC:
6367
AN:
10526
Middle Eastern (MID)
AF:
0.568
AC:
167
AN:
294
European-Non Finnish (NFE)
AF:
0.492
AC:
33402
AN:
67958
Other (OTH)
AF:
0.560
AC:
1182
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1834
3668
5503
7337
9171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.520
Hom.:
62752
Bravo
AF:
0.581

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.681
AC:
83619
AN:
122774
Turkish Variome
AF:
0.576
AC:
3866
AN:
6706
Hom.:
1134
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.659
AC:
5906
AN:
8960
Hom.:
1948
ABraOM SABE-WGS-1171
AF:
0.569
AC:
1332
AN:
2342
Hom.:
379

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.22
DANN
Benign
0.28
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.0030
T
MetaRNN
Benign
0.0000019
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-0.090
N
PhyloP100
-0.18
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.020
N
REVEL
Benign
0.0070
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Varity_R
0.12
gMVP
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs679620;
hg19: chr11-102713620;
COSMIC: COSV55405241;
COSMIC: COSV55405241;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.